AIMEE HUANG: Open Payments
NPI 1710595335 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 32 payments from 5 companies in 2025. Trend: 2023 $482 · 2024 $316 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $290 |
| Gilead Sciences, Inc. | 10 | $256 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $196 |
| ABBVIE INC. | 1 | $27 |
| Celltrion USA Inc. | 1 | $24 |
Products named: REZDIFFRA, XIFAXAN, Epclusa, MAVYRET, VEGZELMA.
Industry payments across NY — which companies pay providers there.
